INTERLEUKIN-5 SYNTHESIS BY EOSINOPHILS - ASSOCIATION WITH GRANULES AND IMMUNOGLOBULIN-DEPENDENT SECRETION

被引:256
作者
DUBUCQUOI, S
DESREUMAUX, P
JANIN, A
KLEIN, O
GOLDMAN, M
TAVERNIER, J
CAPRON, M
CAPRON, A
机构
[1] CHRU,HOP CALMETTE,F-59000 LILLE,FRANCE
[2] CHRU,HOP HURIEZ,SERV GASTROENTEROL,F-59000 LILLE,FRANCE
[3] HOP ERASME,DEPT IMMUNOL,B-1070 BRUSSELS,BELGIUM
[4] ROCHE RES GENT,B-9000 GHENT,BELGIUM
[5] INST PASTEUR,CIBP,F-59019 LILLE,FRANCE
关键词
D O I
10.1084/jem.179.2.703
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 5 (IL-5) is the main factor that promotes the terminal differentiation of eosinophil progenitors (as indicated by colony formation assays), and enhances the effector capacity of mature eosinophils. IL-5 is produced by T lymphocytes, CD4(-)/CD8(-) and mast cells and recently, messenger (m)RNA of this cytokine has been identified in eosinophils from patients with coeliac disease, asthma, or eosinophilic heart diseases. In this study, IL-5 mRNA and immunoreactive IL-5 protein were detected in tissue and blood eosinophils from patients with eosinophilic cystitis or hypereosinophilic syndromes but not in Crohn's disease. By electron microscopy associated to immunogold staining, immunoreactive IL-5 was identified in eosinophilic granules. After stimulation with IgA-, IgE-, or IgG-immune complexes, blood eosinophils were shown, by immunocytochemistry and by enzyme-linked immunosorbent assay, to secrete IL-5. These observations demonstrate that eosinophils, under physiological stimulation, can release significant amounts of IL-5, which may contribute to local eosinophil recruitment and activation.
引用
收藏
页码:703 / 708
页数:6
相关论文
共 19 条
[1]   IMMUNOBIOLOGY AND IMMUNOPATHOLOGY OF HUMAN GUT MUCOSA - HUMORAL IMMUNITY AND INTRAEPITHELIAL LYMPHOCYTES [J].
BRANDTZAEG, P ;
HALSTENSEN, TS ;
KETT, K ;
KRAJCI, P ;
KVALE, D ;
ROGNUM, TO ;
SCOTT, H ;
SOLLID, LM .
GASTROENTEROLOGY, 1989, 97 (06) :1562-1584
[2]  
BRAUM LR, 1993, EUR J IMMUNOL, V23, P956
[3]   EOSINOPHILS EXPRESS INTERLEUKIN-5 AND GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR MESSENGER-RNA AT SITES OF ALLERGIC INFLAMMATION IN ASTHMATICS [J].
BROIDE, DH ;
PAINE, MM ;
FIRESTEIN, GS .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1414-1424
[4]  
DESREUMAUX P, 1993, BLOOD, V82, P1553
[5]   INTERLEUKIN-5 MESSENGER-RNA EXPRESSION BY EOSINOPHILS IN THE INTESTINAL-MUCOSA OF PATIENTS WITH CELIAC-DISEASE [J].
DESREUMAUX, P ;
JANIN, A ;
COLOMBEL, JF ;
PRIN, L ;
PLUMAS, J ;
EMILIE, D ;
TORPIER, G ;
CAPRON, A ;
CAPRON, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :293-296
[6]  
GHAZALEH RA, 1989, J IMMUNOL, V142, P2393
[7]   RELEASE OF BOTH PREFORMED AND NEWLY SYNTHESIZED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA)/CACHECTIN BY MOUSE MAST-CELLS STIMULATED VIA THE FC-EPSILON-RI - A MECHANISM FOR THE SUSTAINED ACTION OF MAST-CELL DERIVED TNF-ALPHA DURING IGE-DEPENDENT BIOLOGICAL RESPONSES [J].
GORDON, JR ;
GALLI, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :103-107
[8]   RECOMBINANT HUMAN INTERLEUKIN-5 IS A SELECTIVE ACTIVATOR OF HUMAN EOSINOPHIL FUNCTION [J].
LOPEZ, AF ;
SANDERSON, CJ ;
GAMBLE, JR ;
CAMPBELL, HD ;
YOUNG, IG ;
VADAS, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) :219-224
[9]   ALKALINE-PHOSPHATASE AND PEROXIDASE FOR DOUBLE IMMUNOENZYMATIC LABELING OF CELLULAR CONSTITUENTS [J].
MASON, DY ;
SAMMONS, R .
JOURNAL OF CLINICAL PATHOLOGY, 1978, 31 (05) :454-460
[10]   EXPRESSION OF MESSENGER-RNA AND IMMUNOREACTIVITY FOR THE GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR IN ACTIVATED HUMAN EOSINOPHILS [J].
MOQBEL, R ;
HAMID, Q ;
YING, S ;
BARKANS, J ;
HARTNELL, A ;
TSICOPOULOS, A ;
WARDLAW, AJ ;
KAY, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) :749-752